Chairman of Task Force of Pakistan Science and Technology Dr Ata ur Rehman told that the mixture of anti-malarial and Erythromycin drugs tried by the Pakistani doctors in treating the Coronavirus patients would have better results.
Dr Ata ur Rehman informed that the Americans had tested Hydroxy chloroquine in treating the Coronavirus patients with no success, while the clinical trial of combination of Hydroxy chloroquine and Erthromycine in Lahore and Karachi would hopefully produce positive results,
He said that the mixture of two drugs was being tested on some 1,100 Coronavirus patients under the direction of University of Health Sciences (UHS) to check their effectiveness.
He added that our scientists, experts and pathologists are working with different approaches in their research for Coronavirus treatment.
He replied a question that its intensity was less harmful in Pakistan as compared to the other European regions. The research was underway in different labs of the Pakistan for identifying the stages of its mutation. It was observed that nine mutations of the virus had entered into the region.
He answered another question that Dr Tahir Shamsi and his team were working on a project of plasma for treating the Coronavirus patients, while Dr S Shah Nawaz along with her team was working on the stem cell. A pharmaceutical company had acquired a shrub from China and the summary for its approval was with the Drugs Regulatory Authority of Pakistan (DRAP).
Eastern Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) viruses had affected different regions of the world in recent times.